Both of the patents, related to technology that measures the amount of oxygen in the user’s blood, are part of a trade-secrets case pending in the US District Court for the Central District of California. Neither figured in the US International Trade Commission’s late-October decision banning imports of certain Apple Watch models.
Apple’s appeal of that ruling is pending at the US Court of Appeals for the Federal Circuit, which also issued Wednesday’s decisions. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
